A Tale of Two Proteases: M<sup>Pro</sup> and TMPRSS2 as Targets for COVID-19 Therapies

A Tale of Two Proteases: M<sup>Pro</sup> and TMPRSS2 as Targets for COVID-19 Therapies

Considering the importance of the 2019 outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) resulting in the coronavirus disease 2019 (COVID-19) pandemic, an overview of two proteases that play an important role in the infection by SARS-CoV-2, the main protease of SARS-CoV-2 (M&l...

Full description

Bibliographic Details
Main Authors:	Barbara Farkaš, Marco Minneci, Matas Misevicius, Isabel Rozas
Format:	Article
Language:	English
Published:	MDPI AG 2023-06-01
Series:	Pharmaceuticals
Subjects:	SARS-CoV-2 MPro TMPRSS2 antiviral protease inhibitor
Online Access:	https://www.mdpi.com/1424-8247/16/6/834

Similar Items

Identification of Triazolopyrimidinyl Scaffold SARS-CoV-2 Papain-Like Protease (PL<sup>pro</sup>) Inhibitor
by: Sebastjan Kralj, et al.
Published: (2024-01-01)

In Silico Study of Secondary Metabolites in Dendrobium spp. as SARS-CoV-2 Antivirus on Main Protease (Mpro)
by: Anggiresti Kinasih, et al.
Published: (2022-03-01)

Association of the Transmembrane Serine Protease-2 (TMPRSS2) Polymorphisms with COVID-19
by: Rosalinda Posadas-Sánchez, et al.
Published: (2022-09-01)

Blockade of TMPRSS2-mediated priming of SARS-CoV-2 by lactoferricin
by: Anna Ohradanova-Repic, et al.
Published: (2022-08-01)

Restriction of Viral Glycoprotein Maturation by Cellular Protease Inhibitors
by: Rishikesh Lotke, et al.
Published: (2024-02-01)

Computational Simulation of HIV Protease Inhibitors to the Main Protease (Mpro) of SARS-CoV-2: Implications for COVID-19 Drugs Design
by: Wei Yu, et al.
Published: (2021-12-01)

Development of potent and effective SARS-CoV-2 main protease inhibitors based on maleimide analogs for the potential treatment of COVID-19
by: Karol Biernacki, et al.
Published: (2024-12-01)

Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2–Priming Protease TMPRSS2
by: Nurit P Azouz, et al.
Published: (2021-04-01)

Computer-aided approaches reveal trihydroxychroman and pyrazolone derivatives as potential inhibitors of SARS-CoV-2 virus main protease
by: Atatreh Noor, et al.
Published: (2021-09-01)

Allosteric Binding Sites of the SARS-CoV-2 Main Protease: Potential Targets for Broad-Spectrum Anti-Coronavirus Agents
by: Alzyoud L, et al.
Published: (2022-08-01)

Publication trend of TMPRSS2 as SARS-CoV-2 receptor during the COVID-19 pandemic
by: Lalu Muhammad Irham, et al.
Published: (2023-03-01)

The Transmembrane Protease Serine 2 (TMPRSS2) Non-Protease Domains Regulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike-Mediated Virus Entry
by: Romano Strobelt, et al.
Published: (2023-10-01)

TMPRSS2, a SARS-CoV-2 internalization protease is downregulated in head and neck cancer patients
by: Andrea Sacconi, et al.
Published: (2020-09-01)

Variations in levels of ACE2 and TMPRSS2 receptors among COVID-19
by: Dalia Zanaty, et al.
Published: (2024-02-01)

Systematic Search for SARS-CoV-2 Main Protease Inhibitors for Drug Repurposing: Ethacrynic Acid as a Potential Drug
by: Camilla Isgrò, et al.
Published: (2021-01-01)

Advances in the Search for SARS-CoV-2 M<sup>pro</sup> and PL<sup>pro</sup> Inhibitors
by: Marcel Arruda Diogo, et al.
Published: (2024-09-01)

In Silico Screening of Novel TMPRSS2 Inhibitors for Treatment of COVID-19
by: Shuo Wang, et al.
Published: (2022-06-01)

A Polymorphism in the TMPRSS2 Gene Increases the Risk of Death in Older Patients Hospitalized with COVID-19
by: Clara Caldeira de Andrade, et al.
Published: (2022-11-01)

SARS-CoV-2 M<sup>pro</sup> Inhibitors: Achieved Diversity, Developing Resistance and Future Strategies
by: Conrad Fischer, et al.
Published: (2023-01-01)

<i>In Silico</i> Molecular Characterization of Human TMPRSS2 Protease Polymorphic Variants and Associated SARS-CoV-2 Susceptibility
by: Mohd Zulkifli Salleh, et al.
Published: (2022-02-01)

Towards potential inhibitors of COVID-19 main protease Mpro by virtual screening and molecular docking study
by: Moujane Soumia, et al.
Published: (2020-01-01)

ACE2 and TMPRSS2 Immunolocalization and COVID-19-Related Thyroid Disorder
by: Gi-Cheol Park, et al.
Published: (2022-04-01)

Targeting SARS-CoV-2 Proteases for COVID-19 Antiviral Development
by: Zongyang Lv, et al.
Published: (2022-02-01)

Inhibitors of SARS-CoV-2 Main Protease (Mpro) as Anti-Coronavirus Agents
by: Agnieszka Zagórska, et al.
Published: (2024-07-01)

A Computational Approach to Elucidate the Interactions of Chemicals From Artemisia annua Targeted Toward SARS-CoV-2 Main Protease Inhibition for COVID-19 Treatment
by: Titilayo Omolara Johnson, et al.
Published: (2022-06-01)

Link of TMPRSS2 expression with tumor immunogenicity and response to immune checkpoint inhibitors in cancers
by: Karthikeyan Subbarayan, et al.
Published: (2025-03-01)

ACE-2, TMPRSS2 and Beyond; Promising Targets and Tools for COVID-19 Prophylaxis and Treatment
by: Akçahan GEPDİREMEN, et al.
Published: (2020-12-01)

Comprehensive fitness landscape of SARS-CoV-2 Mpro reveals insights into viral resistance mechanisms
by: Julia M Flynn, et al.
Published: (2022-06-01)

Developing evolution-resistant drugs for COVID-19
by: Daniel M Weinreich
Published: (2022-07-01)

Hemi-Babim and Fenoterol as Potential Inhibitors of MPro and Papain-like Protease against SARS-CoV-2: An In-Silico Study
by: Ahmad Alzamami, et al.
Published: (2022-04-01)

Recent changes in the mutational dynamics of the SARS-CoV-2 main protease substantiate the danger of emerging resistance to antiviral drugs
by: Lena Parigger, et al.
Published: (2022-12-01)

Expression Pattern of the SARS-CoV-2 Entry Genes <i>ACE2</i> and <i>TMPRSS2</i> in the Respiratory Tract
by: Yichuan Liu, et al.
Published: (2020-10-01)

TMPRSS2 Expression and Activity Modulation by Sex-Related Hormones in Lung Calu-3 Cells: Impact on Gender-Specific SARS-CoV-2 Infection
by: Donatella Treppiedi, et al.
Published: (2022-05-01)

ACE2 and TMPRSS2 expression in patients before, during, and after SARS-CoV-2 infection
by: Henrique Borges da Silva Grisard, et al.
Published: (2024-03-01)

Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity
by: Silvia Martinez-Diz, et al.
Published: (2023-06-01)

Development of a Cell-Based Luciferase Complementation Assay for Identification of SARS-CoV-2 3CL<sup>pro</sup> Inhibitors
by: Jonathan M. O. Rawson, et al.
Published: (2021-01-01)

TMPRSS2 as a Key Player in Viral Pathogenesis: Influenza and Coronaviruses
by: Gilmara Barros de Lima, et al.
Published: (2025-01-01)

TMPRSS2 gene polymorphism common in East Asians confers decreased COVID-19 susceptibility
by: Takeshi Sekiya, et al.
Published: (2022-11-01)

Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 M<sup>pro</sup>, Impairing Variants Replication In Vitro and In Vivo
by: Otávio Augusto Chaves, et al.
Published: (2021-12-01)

Design, Synthesis and Evaluation of Fused Bicyclo[2.2.2]octene as a Potential Core Scaffold for the Non-Covalent Inhibitors of SARS-CoV-2 3CL<sup>pro</sup> Main Protease
by: Barbara Herlah, et al.
Published: (2022-04-01)